Triple-Threat vaccine aims to shield seniors from three respiratory viruses
⭐️ VACCINE ⭐️
Ongoing
This study tests two new vaccines (SCB-1022 and SCB-1033) designed to protect against RSV, human metapneumovirus, and parainfluenza virus. About 612 healthy adults aged 60-85 will receive either a vaccine or a placebo. The main goal is to check safety and how well the vaccines tr…
Phase: PHASE1, PHASE2 • Sponsor: Clover Biopharmaceuticals AUS Pty • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:35 UTC